AEON Biopharma, Inc. (AEON)
(Real Time Quote from BATS)
$1.45 USD
-0.05 (-3.33%)
Updated May 30, 2024 03:28 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Brokerage Reports
0 items in cart
AEON Biopharma, Inc. [AEON]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: AEON Biopharma, Inc.
Industry: Unclassified
Alignment With FDA Charts Path Forward in Chronic and Episodic Migraine; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: AEON Biopharma, Inc.
Industry: Unclassified
ABP-450 Shows Impressive Effect in Treating Episodic Migraine
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: AEON Biopharma, Inc.
Industry: Unclassified
Aeon Looks Poised to Disrupt the Blockbuster Neurotoxin Market; Initiate at Buy With $18 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
|